Latest Market Growth News

Control Bionics has delivered its strongest US sales quarter in years, nearing US$1 million in revenue, while broadening its market footprint with new commercial agreements and cost optimizations.

Little Green Pharma reports a robust 75% revenue increase to $9.5 million for December quarter, driven by strong European market growth and strategic product launches.

Syrah Resources faced operational setbacks at its Balama graphite mine due to protests, prompting a force majeure declaration, yet it maintains a robust cash position and advances its downstream Vidalia anode material facility amid growing market demand.

Syrah Resources faces significant operational disruption at its Balama graphite mine due to ongoing protests, declaring force majeure while advancing its US-based Vidalia facility amid strong EV market growth.

NIMY Resources has reported record-high gallium grades at its Block 3 East prospect, positioning itself as a potential key supplier in a market set to surge tenfold by 2034.

Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.

FleetPartners Group Limited reported a robust 13% increase in adjusted EPS for FY24, propelled by targeted market growth, operational transformation, and a disciplined share buy-back program. The company remains optimistic about sustaining momentum despite a modest dip in new business writings in early FY25.

Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.

Montaka Global Long Only Equities Fund has announced a distribution of 11.30 cents per unit for the half-year ending 31 December 2024, continuing its commitment to delivering steady income alongside capital growth.